Healthways Inc. (NASDAQ:HWAY)’s share price reached a new 52-week high during trading on Tuesday . The company traded as high as $27.30 and last traded at $25.86, with a volume of 897,508 shares. The stock had previously closed at $25.87.

HWAY has been the subject of a number of recent research reports. Oppenheimer Holdings Inc. upgraded shares of Healthways to an “outperform” rating and set a $27.00 price objective for the company in a research note on Sunday, August 14th. FBR & Co increased their price objective on shares of Healthways from $16.00 to $21.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 10th. Jefferies Group increased their price objective on shares of Healthways from $13.00 to $18.50 and gave the stock a “hold” rating in a research note on Thursday, August 4th. Barclays PLC upgraded shares of Healthways from an “underweight” rating to an “equal weight” rating and increased their price objective for the stock from $12.00 to $27.00 in a research note on Monday, August 22nd. Finally, Piper Jaffray Cos. upped their target price on shares of Healthways from $15.00 to $25.50 and gave the company an “overweight” rating in a report on Wednesday, August 10th. Two investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Healthways currently has a consensus rating of “Buy” and a consensus price target of $22.93.

The company’s market cap is $939.97 million. The firm’s 50-day moving average is $23.13 and its 200-day moving average is $14.54.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/20/healthways-inc-hway-sets-new-52-week-high-at-27-30.html

Healthways (NASDAQ:HWAY) last posted its quarterly earnings results on Tuesday, August 9th. The company reported $0.54 earnings per share for the quarter, beating the consensus estimate of $0.01 by $0.53. Healthways had a negative net margin of 31.32% and a positive return on equity of 8.83%. The firm earned $125 million during the quarter, compared to the consensus estimate of $186.88 million. During the same period in the previous year, the firm posted $0.11 earnings per share. The business’s revenue was up 10.2% compared to the same quarter last year. Equities analysts anticipate that Healthways Inc. will post $2.11 earnings per share for the current year.

In other Healthways news, Director Mary Jane England sold 3,816 shares of Healthways stock in a transaction on Friday, August 26th. The shares were sold at an average price of $24.78, for a total value of $94,560.48. Following the completion of the sale, the director now directly owns 39,068 shares of the company’s stock, valued at $968,105.04. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. 14.01% of the stock is currently owned by company insiders.

A number of large investors have recently bought and sold shares of the stock. Acrospire Investment Management LLC increased its stake in Healthways by 80.9% in the second quarter. Acrospire Investment Management LLC now owns 9,612 shares of the company’s stock valued at $111,000 after buying an additional 4,300 shares during the period. Quantitative Systematic Strategies LLC bought a new stake in Healthways during the second quarter valued at $118,000. Profund Advisors LLC increased its stake in Healthways by 4.5% in the second quarter. Profund Advisors LLC now owns 10,668 shares of the company’s stock valued at $123,000 after buying an additional 456 shares during the period. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA increased its stake in Healthways by 7.6% in the second quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA now owns 11,685 shares of the company’s stock valued at $135,000 after buying an additional 825 shares during the period. Finally, KBC Group NV bought a new stake in Healthways during the second quarter valued at $147,000. 92.52% of the stock is owned by hedge funds and other institutional investors.

Healthways Company Profile

Healthways, Inc (Healthways) provides network delivered solutions and population health management services that are designed to help people manage their wellbeing, thereby managing their health and productivity, and their health-related costs. The Company operates in the domestic and international segments, which are collectively known as the well-being improvement services segment.

5 Day Chart for NASDAQ:HWAY

Receive News & Ratings for Healthways Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthways Inc. and related companies with MarketBeat.com's FREE daily email newsletter.